Vaccines Alone Cannot Slow the Evolution of SARS-CoV-2.

Van Egeren, Debra; Stoddard, Madison; White, Laura F; Hochberg, Natasha S; Rogers, Michael S; Zetter, Bruce; Joseph-McCarthy, Diane; Chakravarty, Arijit

Van Egeren, Debra; Stoddard, Madison; White, Laura F; Hochberg, Natasha S; Rogers, Michael S; Zetter, Bruce; Joseph-McCarthy, Diane; Chakravarty, Arijit.

Afiliación

Van Egeren D; Department of Medicine, Weill Cornell Medicine, New York, NY 10021, USA.
Stoddard M; New York Genome Center, New York, NY 10013, USA.
White LF; Fractal Therapeutics, Lexington, MA 02420, USA.
Hochberg NS; Department of Biostatistics, Boston University School of Public Health, Boston, MA 02118, USA.
Rogers MS; Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA.
Zetter B; Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA.
Joseph-McCarthy D; Department of Surgery, Harvard Medical School, Boston, MA 02115, USA.
Chakravarty A; Vascular Biology Program, Boston Children's Hospital, Boston, MA 02115, USA.

Vaccines (Basel) ; 11(4)2023 Apr 16.

Article en En | MEDLINE | ID: mdl-37112765

Palabras clave

SARS-CoV-2; evolution; immune evasion; mathematical modeling; viral variants

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Vaccines (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google